In the BioHarmony Drug Report Database
Heparin
Heparin Sodium (heparin) is an unknown pharmaceutical. It is marketed in the US. The pharmaceutical is active against antithrombin-III. In addition, it is known to target epidermal growth factor receptor, spike glycoprotein, and receptor tyrosine-protein kinase erbB-4.
Trade Name
|
Heparin Sodium |
|---|---|
Common Name
|
heparin |
ChEMBL ID
|
CHEMBL1909300 |
Indication
|
cerebral infarction, coronary thrombosis, myocardial infarction, postoperative complications, pulmonary embolism, thromboembolism, thrombophlebitis, unstable angina |
Drug Class
|
Image (chem structure or protein)
